Announcements Trials
Browse Landscape

Status

Completed 60Unknown 34Recruiting 30Not yet recruiting 8Active not recruiting 7Withdrawn 4Terminated 4Enrolling by invitation 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 16Observational 4

Sponsor

Cancer Type

Gastrointestinal 94Breast 76Genitourinary 75Thoracic 54Other hematologic neoplasm 46Lymphoid 37Tumor-Agnostic 35CNS 34Gynecologic 28Head & Neck 27Dermatologic 23Sarcoma 12Myeloid 11Plasma cell 9Other 8Other solid neoplasm 6Other neoplasm 5Endocrine 5Classical hematology 5NET 4

Conditions

Neuroendocrine Tumors 4Pancreatic Neoplasms 1Neoplasms 1Carcinoid Tumor 1Cachexia 1Adrenal Gland Neoplasms 1

Interventions

telotristat ethyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Observational × NET × Clear all
NCT04432532 2025-02-10

NETAT

University of Pennsylvania

Withdrawn
EndocrineNET

Adrenal Gland Neoplasms, Neuroendocrine Tumors

NCT00657332 2023-11-28

Clinical and Pathologic Studies in Neuroendocrine Tumors

Stanford University

Withdrawn
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT04034745 2020-12-30

Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain

Cedars-Sinai Medical Center

Withdrawn
EndocrineGastrointestinalNET

Cachexia, Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

NCT03895463 2020-11-05

NETways

Ipsen

Withdrawn
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡